Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
NCT03030235
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
324
Enrollment
OTHER
Sponsor class
Conditions
Chronic Heart Failure With Preserved Systolic Function
Interventions
DRUG:
Dapagliflozin 10Mg Oral Tablet
DRUG:
Dapagliflozin matching placebo
Sponsor
Saint Luke's Health System